The industry is on the threshold of bringing into commercial production a new generation of transformative skin-mediated delivery systems. This two-day conference brings together leading researchers in the field to share the most recent advances in the design, formulation, and delivery of skin-mediated therapies and vaccines.

Don't miss more than 300 global suppliers exhibiting across four floors; an inspiring and educational two-day Conference; the highly popular Women in MedTech Forum; and unrivalled networking and business opportunities.

The conference will explore new innovation and challenges in protein formulation for novel modalities targeting stability, high concentration, aggregation, and immunogenicity, impacting drugs like monoclonal antibodies, biospecifics, peptides, ADCs, AAV, and DNA/RNA-based therapies. Attending the event will enable you to learn how to tackle key challenges in developing drugs and enhance patient delivery on a larger scale, as well as improve the quality and control of drug manufacturing, and boost the responsiveness in producing long-acting drugs to match global needs.

The largest event on pre-filled syringes and injection devices brings together key field players to discuss the breakthroughs propelling the industry. A comprehensive agenda covers critical topics including sustainability, large-volume injections, digital health, and regulatory compliance. The exhibit hall with 140+ vendors, poster presentations, lightning sessions, networking activities, and Drug Delivery Innovation Awards make this event a must-attend.

Regulatory agencies are requiring stricter standards for environmental monitoring systems, facility cleaning and disinfectant qualification, aseptic cleanroom operations, filtration, sterilization, and aseptic process simulation (or media fill). This two-day summit features comprehensive coverage of barrier, containment, and best practice aseptic technologies.

E&L examination is continuously growing in importance. Given the current scrutiny from governing bodies including the US FDA and MHRA, understanding the best practices and guidelines to carry out E&L studies is imperative in order to eliminate risk and potential development delays. Smithers has been organising the European Extractables & Leachables conferences for >15 years and has a long history of running regulatory conferences. This event will provide you with the most up-to-date information.

This two-day conference will explore safety, quality, and regulatory challenges in pharmaceutical and biotech industries, focusing on drug packaging, delivery components, and single-use systems. Key topics include recent USP chapter revisions, FDA guidances, and international regulations for best practices in materials and chemistry characterization for drugs, biologics, and packaging.

Experience the forefront of Inhalation & Respiratory Drug Delivery at RESCON Summit. Engage in enriching discussions, forge valuable connections, and stay abreast of the latest advancements in inhalation therapies. With a focus on business-to-business collaborations, this premier event is your gateway to driving innovation in respiratory health. Join industry leaders and shape the future of patient care at RESCON Summit.

RDD Asia 2024, co-organised with Aptar Pharma, features expert talks on pMDIs, DPIs, nebulisers, nasal sprays, and emerging aerosol delivery platforms. The conference includes discussions on generic product development, new therapeutic opportunities, drug development progress, and novel test methods. It also offers poster sessions, exhibit tables, workshops, and networking opportunities, focusing on regulatory harmonisation, academic collaboration, and commercial development.

Join the world's leading experts in Inhalation and Respiratory Drug Delivery at the 7th annual conference in Milan, Italy. On March 6-7, 2024, medical, pharmacology, and healthcare specialists will gather to discuss the latest advancements and techniques in respiratory drug delivery. Don't miss this opportunity to expand your knowledge and network with industry leaders. Register now!

Advances in digital health and connected devices are revolutionizing the parenteral drug delivery landscape. This two-day summit features expert insight into next-generation CP product development, and the complex quality, safety, and regulatory compliance issues facing the industry.

The Drug Delivery to the Lungs (DDL) Conference is in it’s 35th year and attracts in excess of 1000 attendees worldwide, including scientists, academics, clinicians, regulators and industry experts. The conference includes a large industry exhibition, supported by over 100 international companies, a scientific poster hall, expert lectures and excellent networking opportunities over the three-day event.

The US-Japan Symposium on Drug Delivery Systems is a biennial event offering presentations by academic and industry researchers from a number of disciplines, from the life sciences to engineering, on a range of topics including peptide and protein delivery, gene delivery, cell delivery, vaccines, transdermal, pulmonary and new materials.

RDD Europe 2025, co-organised with Aptar Pharma, features in-depth discussions on pulmonary and nasal drug delivery, including therapeutic opportunities, product design, and advanced test methods. Themed Knowledge Spaces integrate, expert speakers, posters, exhibit tables, online company profiles, workshops, and networking opportunities. It aims to enhance regulatory science, business and academic partnerships and emerging scientist participation.

RDD 2026 is a must-attend, international conference, part of a series that has run continuously since 1988 and garnered a sustained reputation for excellent content covering all aspects of drug delivery to the lungs and nose. In-depth presentations and discussion of pioneering science in tandem with exceptional opportunities for networking will appeal to scientists, engineers, regulators, clinicians, solutions providers, and business professionals active in this exciting field.